2030年地中海鱼类疫苗市场预测 - COVID-19影响和区域分析 - 疫苗类型(灭活疫苗、减毒活疫苗、类毒素疫苗、亚单位疫苗、结合疫苗和重组载体疫苗)、给药途径(浸泡疫苗、注射)疫苗和口服疫苗)、物种(大菱鲆、欧洲鳀鱼和鲈鱼、三文鱼、地中海鲈鱼、普通牙鲷和普通潘多拉鱼、海鲷、虹鳟、黑鲷、鳟鱼、地中海旗鱼和蓝鳍金枪鱼、石斑鱼和琥珀鱼,以及其他)和国家/地区

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 199    |    Report Code: BMIRE00028804    |    Category: Life Sciences

Explore in Your Language
Mediterranean Fish Vaccine Market

地中海鱼苗市场规模预计将从2022年的963.2346亿美元增至2030年的2090.308亿美元;预计 2022 年至 2030 年复合年增长率为 10.2%。

消费者越来越意识到动物蛋白的营养价值。对更少或不含药物的健康、可持续、高质量肉制品的需求也在迅速增长。对水生动物食品(油、鱼子酱、蛋白粉、肉类等)的需求不断增长,鼓励农民接种疫苗,以保障水产养殖并获得高利润。

作为健康饮食的一部分,经常食用鱼类被广泛提倡。与陆生动物肉相比,鱼类的蛋白质含量较高,这一点通过饲料转化率 (FCR) 低于陆生动物即可看出。此外,鱼蛋白易消化且富含必需氨基酸,这与必需氨基酸含量较低的动物源蛋白不同。通过不同的研究,食用鱼类和贝类与降低心脏病、炎症和关节炎的风险有关。鱼的健康益处主要与长链 omega 3 (n-3) 多不饱和脂肪酸 (PUFA) 的存在有关。此外,鱼蛋白富含生物活性肽,如果以适当的浓度食用以支持其在人体内的最佳生物利用度,则可以提供许多健康益处。食用鱼类的其他健康益处包括通过抑制肾素-血管紧张素-醛固酮系统(RAAS)内的酶来控制血压;维持骨骼健康;控制炎症(抗氧化肽);通过阿片肽和血小板激活因子乙酰水解酶(PAF-AH)抑制肽的作用维持心理健康;等等。因此,水生动物源性蛋白质对健康的巨大益处表明需要健康饲养这些动物,从而推动地中海地区对鱼类疫苗的需求。

新型疫苗开发:地中海鱼苗市场机遇

细菌、病毒、寄生虫引起的各种疾病暴发,减缓了全球水产养殖的进程行业几十年。除了危害人类健康外,新出现的疾病也极大地影响水生动物。疫苗接种是一种众所周知的、有效的预防措施,用于解决这个问题。然而,传统疫苗仍然存在一些缺点和局限性,这促使研究人员将注意力转向嵌合多表位疫苗等新型疫苗。基于目前对基因组学和免疫蛋白质组学的理解以及目前可用的生物信息学工具,研究人员现在可以识别免疫细胞识别的潜在目标表位。此外,随着全基因组测序等技术的成本持续下降,它为物种特异性疫苗的开发开辟了道路。这些因素可能会鼓励地中海鱼类疫苗市场参与者投资开发针对目前尚无疫苗的病毒、寄生虫或细菌传染病的新疫苗。

此外,有效粘膜疫苗的开发及其管理流程的优化预计将加速新型疫苗的开发,进而鼓励地中海国家的水产养殖企业规范鱼类疫苗接种流程。紧急(自体)疫苗的有效使用预计将有助于应对新出现的疾病挑战,并为市场参与者创造巨大的发展机会。

地中海鱼类疫苗市场细分为疫苗类型、种类、给药途径、临床适应症和国家。根据疫苗类型,市场分为灭活疫苗、减毒活疫苗、类毒素疫苗、亚单位疫苗、结合疫苗和重组载体疫苗。根据物种,地中海鱼类疫苗市场分为大菱鲆、欧洲鳀鱼和鲈鱼、鲑鱼、地中海鲈鱼、普通齿鱼和普通潘多拉鱼、鲷鱼、虹鳟、黑鲷、鳟鱼、地中海箭鱼和蓝鳍金枪鱼、石斑鱼和琥珀鱼等。从给药途径来看,市场分为浸没疫苗、注射疫苗和口服疫苗。并根据临床适应症,市场分为细菌感染和病毒感染。根据地区,对法国、意大利、西班牙、埃及、希腊、土耳其、以色列和地中海其他地区的市场进行了分析。该地区市场的增长是由蓬勃发展的水产养殖业和加强疫苗研发的举措推动的。土耳其在世界上最大的海水鱼类养殖国中排名第九,其水产养殖产量在所有欧洲国家中名列前茅。水产养殖占土耳其海鲜年产量的 44.6% 左右。该国声称拥有世界上增长最快的食品生产工业。土耳其拥有 434 个正在运营的海水养殖设施,生产金头鲷和欧洲鲈鱼。过去二十年,技术进步促进了鲈鱼和鲷鱼产量的快速增长。因此,该国已成为世界上最大的鲷鱼和鲈鱼生产国,满足全球约 40% 的需求。此外,由于政府努力将鱼类推广为低碳足迹的健康产品,该国的鱼类消费量正在上升。根据土耳其海洋研究基金会 (TUDAV) 2021 年 1 月发布的估计,到 2023 年,该国的鱼类产量将达到 60 万吨,出口额为 170 万美元(160 万欧元)。

另一方面,管理水产养殖和养鱼场的各种疾病是土耳其水产养殖企业面临的主要挑战。这一挑战可以通过定期鱼类疫苗接种来应对。因此,土耳其大规模的鱼类生产可能会扩大未来几年对鱼类疫苗的需求。

联合国粮食及农业组织(FAO)、经济合作与发展组织(OECD)、欧盟、土耳其海洋研究基金会( TUDAV)是准备地中海鱼类疫苗市场报告时提到的一些关键的主要和次要来源。



Mediterranean Fish Vaccine Strategic Insights

Strategic insights for Mediterranean Fish Vaccine involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/mediterranean-fish-vaccine-market-strategic-framework.webp
Get more information on this report

Mediterranean Fish Vaccine Report Scope

Report Attribute Details
Market size in 2022 US$ 96,323.46 Million
Market Size by 2030 US$ 2,09,030.80 Million
Global CAGR (2022 - 2030) 10.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 疫苗类型
  • 灭活疫苗
  • 减毒活疫苗
  • 类毒素疫苗
  • 亚单位疫苗
  • 结合疫苗
  • 重组载体疫苗
By 接种途径
  • 浸入疫苗
  • 注射疫苗
  • 口服疫苗
By 种类
  • 大菱鲆
  • 欧洲凤尾鱼
  • 鲈鱼
  • 鲑鱼
  • 地中海鲈鱼
  • 牙鲷
  • 普通斑鱼
  • é²·é±¼
  • 彩虹濑鱼
  • 金枪鱼
  • 鳟鱼
  • 地中海剑鱼
  • 蓝鳍金枪鱼
  • 石斑鱼和琥珀鱼
Regions and Countries Covered 地中海
  • 地中海
Market leaders and key company profiles
  • Zoetis Inc.
  • Merck & Co Inc
  • HIPRA SA
  • ICTYODEV SAS
  • Acuipharma Aquaculture Health SL
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Ceva SA
  • Get more information on this report

    Mediterranean Fish Vaccine Regional Insights

    The regional scope of Mediterranean Fish Vaccine refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/mediterranean-fish-vaccine-market-geography.webp
    Get more information on this report

    The List of Companies - Mediterranean Fish Vaccine Market

    1. Zoetis Inc.
    2. Merck & Co Inc
    3. HIPRA SA
    4. ICTYODEV SAS
    5. Acuipharma Aquaculture Health SL
    6. Phibro Animal Health Corp
    7. Vaxxinova International BV
    8. Kyoto Biken Laboratories Inc
    9. Elanco Animal Health Inc
    10. Ceva SA
    Frequently Asked Questions
    How big is the Mediterranean Fish Vaccine Market?

    The Mediterranean Fish Vaccine Market is valued at US$ 96,323.46 Million in 2022, it is projected to reach US$ 2,09,030.80 Million by 2030.

    What is the CAGR for Mediterranean Fish Vaccine Market by (2022 - 2030)?

    As per our report Mediterranean Fish Vaccine Market, the market size is valued at US$ 96,323.46 Million in 2022, projecting it to reach US$ 2,09,030.80 Million by 2030. This translates to a CAGR of approximately 10.2% during the forecast period.

    What segments are covered in this report?

    The Mediterranean Fish Vaccine Market report typically cover these key segments-

  • 疫苗类型 (灭活疫苗, 减毒活疫苗, 类毒素疫苗, 亚单位疫苗, 结合疫苗, 重组载体疫苗)
  • 接种途径 (浸入疫苗, 注射疫苗, 口服疫苗)
  • 种类 (大菱鲆, 欧洲凤尾鱼, 鲈鱼, 鲑鱼, 地中海鲈鱼, 牙鲷, 普通斑鱼, 鲷鱼, 彩虹濑鱼, 金枪鱼, 鳟鱼, 地中海剑鱼, 蓝鳍金枪鱼, 石斑鱼和琥珀鱼)
  • What is the historic period, base year, and forecast period taken for Mediterranean Fish Vaccine Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Mediterranean Fish Vaccine Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Mediterranean Fish Vaccine Market?

    The Mediterranean Fish Vaccine Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Zoetis Inc.
  • Merck & Co Inc
  • HIPRA SA
  • ICTYODEV SAS
  • Acuipharma Aquaculture Health SL
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Ceva SA
  • Who should buy this report?

    The Mediterranean Fish Vaccine Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Mediterranean Fish Vaccine Market value chain can benefit from the information contained in a comprehensive market report.